Kostal Pharma Labs Private Limited

Kostal Pharma Labs Private Limited - pharma in Peddapuram, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U51397AP2003PTC042217 Incorporated 12 December 2003 ROC Vijayawada HQ Peddapuram, Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2023
₹6.32 Cr
▼ 20% YoY
Net profit · FY 2023
₹1.9 Lakh
Net margin 0.3%
EBITDA · FY 2023
₹31.6 Lakh
EBITDA margin 5%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.41 Cr
Issued & subscribed
Open charges
₹1.3 Cr
Satisfied ₹28 Lakh
Company age
23 yrs
Est. 2003
Employees · EPFO
12
Provident fund records

About Kostal Pharma Labs Private Limited

Data last updated:

Kostal Pharma Labs Private Limited is a private limited company based in Peddapuram, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U51397AP2003PTC042217. Its GSTIN is 37AAECA9377P1ZS (Andhra Pradesh).

The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.41 Cr. It was formerly known as Abhaya Medicine Mart Private Limited. It is led by directors including Kasiviswanadha Rao Remella (Managing Director) and Lakshmi Remella.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 71 To 78 Industrial Park Phase I, Peddapuram, Andhra Pradesh, India – 533437.

As per the financials filed for FY 2023, the company reported a revenue of ₹6.32 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.9 Lakh (net margin 0.3%) and EBITDA of ₹31.6 Lakh (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 9% over five years.

The company has about 12 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹1.3 Cr and satisfied charges of ₹28 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Kostal Pharma Labs Private Limited
CIN U51397AP2003PTC042217
Registration Number 042217
Incorporation Date 12 December 2003
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No. 71 To 78 Industrial Park Phase I, Peddapuram, Andhra Pradesh, India – 533437
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Kostal Pharma Labs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Kostal Pharma Labs Private Limited report

Financials, compliance, directors, charges, ownership and filings for Kostal Pharma Labs Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Financials of Kostal Pharma Labs Private Limited FY 2025 filings available

Kostal Pharma Labs Private Limited reported revenue of ₹6.32 Cr (down 20% YoY) for FY 2023.

Revenue · FY 2023
₹6.32 Cr ▼ 20%
Net profit · FY 2023
₹1.9 Lakh margin 0.3%
EBITDA · FY 2023
₹31.6 Lakh margin 5%

Compounded Annual Growth Rate (CAGR) of Kostal Pharma Labs Private Limited

Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 5%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 49%
3 years · compounded
▼ 1%
5 years · compounded
▼ 2%

Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Kostal Pharma Labs Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations₹6.32 Cr••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹31.6 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.9 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Kostal Pharma Labs Private Limited

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin5%••••••••••••••••
Net Profit Margin0.3%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kostal Pharma Labs are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Auditor Details of Kostal Pharma Labs Private Limited

Kostal Pharma Labs Private Limited is audited by Brahmananda Reddy & Associates for the financial year 2023.

NameStatusAppointment DateCessation Date
Brahmananda Reddy & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Kostal Pharma Labs Private Limited

Kostal Pharma Labs has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Lakshmi RemellaDirector29 Jun 201115 Years 3 MonthsCurrent
Kasiviswanadha Rao RemellaManaging Director12 Dec 200322 Years 10 MonthsCurrent
Vishnu Vardhan RemellaDirector12 Dec 200322 Years 10 MonthsCurrent

Ownership and Shareholding of Kostal Pharma Labs Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Kostal Pharma Labs Private Limited

Open charges
₹1.3 Cr
Satisfied charges
₹28 Lakh
Breakdown by lending institutions
Indian Overseas Bank₹1.30 Cr
Latest charge details
DateLenderAmountStatus
27 Apr 2011Indian Overseas Bank₹1.3 CrOpen
01 Nov 2021Indian Overseas Bank₹28 LakhSatisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Kostal Pharma Labs Private Limited

Kostal Pharma Labs Private Limited has a workforce of 12 employees as of Mar 28, 2024.

Employee count
12
Active EPFO establishments
1
Employee growth
-14.29%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Kostal Pharma Labs Private Limited

Kostal Pharma Labs Private Limited has 6 board changes on record since 2003: 3 appointments and 3 cessations. The latest: Durga Deepti Kalakonda ceased to be Director on 12 Oct 2017.

AGM
Kostal Pharma Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Indian Overseas Bank of Rs. 1.30 Cr registered on 27 Apr 2011 with Charge ID 10292126 was modified on 01 Aug 2025.
Filing
Kostal Pharma Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge registered on 01 Nov 2021 via Charge ID 100503401 with Indian Overseas Bank was fully satisfied on 26 Feb 2024.
Charges
A charge with Indian Overseas Bank amounted to Rs. 0.28 Cr with Charge ID 100503401 was registered on 01 Nov 2021.
Ceased
Durga Deepti Kalakonda ceased to be Director.
Ceased
Kasiviswanadha Rao Remella ceased to be Director.
Ceased
Raviteja Seshavataram Rao ceased to be Director.
Appointed
Lakshmi Remella was appointed as Director.
Charges
A charge with Indian Overseas Bank amounted to Rs. 1.30 Cr with Charge ID 10292126 was registered on 27 Apr 2011.
Appointed
Kasiviswanadha Rao Remella was appointed as Managing Director.
Appointed
Vishnu Vardhan Remella was appointed as Director.

1 earlier event is listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Kostal Pharma Labs Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Kostal Pharma Labs Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Kostal Pharma Labs Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Kostal Pharma Labs Private Limited

Kostal Pharma Labs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAECA9377P1ZSAndhra PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Kostal Pharma Labs Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kostal Pharma Labs Private Limited

Kostal Pharma Labs is an active private limited company based in Peddapuram, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2003 (23+ years old) and is registered under CIN U51397AP2003PTC042217.

Kostal Pharma Labs reported revenue of ₹6.32 Cr for FY 2023 (down 20% YoY).

Kostal Pharma Labs has 3 current directors:

Kostal Pharma Labs reported a net profit of ₹1.9 Lakh (net margin 0.3%) and EBITDA of ₹31.6 Lakh (EBITDA margin 5%) for FY 2023, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Kostal Pharma Labs is 5% over three years and 9% over five years. In the latest year (FY 2023) revenue fell 20%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Kostal Pharma Labs is 37AAECA9377P1ZS, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Kostal Pharma Labs is U51397AP2003PTC042217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Kostal Pharma Labs was incorporated on 12 December 2003, making it 23+ years old. It is registered with the Registrar of Companies, Vijayawada.

Durga Deepti Kalakonda ceased to be Director on 12 Oct 2017. Kasiviswanadha Rao Remella ceased to be Director on 12 Oct 2017. Raviteja Seshavataram Rao ceased to be Director on 12 Oct 2017. Kostal Pharma Labs has 6 board changes on record in total.

The registered office of Kostal Pharma Labs is at Plot No. 71 To 78 Industrial Park Phase I, Peddapuram, Andhra Pradesh, India – 533437.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available